| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.22T | 531.26B | 518.28B | 488.48B | 503.06B |
| Gross Profit | 657.18B | 531.26B | 518.28B | 584.72B | 604.08B |
| EBITDA | 329.32B | 324.18B | 0.00 | 312.51B | 305.41B |
| Net Income | 243.02B | 237.84B | 231.90B | 226.52B | 216.56B |
Balance Sheet | |||||
| Total Assets | 38.36T | 35.06T | 32.43T | 28.91T | 26.72T |
| Cash, Cash Equivalents and Short-Term Investments | 5.09T | 5.27T | 4.46T | 4.10T | 3.90T |
| Total Debt | 2.78T | 2.52T | 2.21T | 1.89T | 1.72T |
| Total Liabilities | 35.15T | 32.11T | 29.68T | 26.33T | 24.37T |
| Stockholders Equity | 3.06T | 2.82T | 2.63T | 2.43T | 2.23T |
Cash Flow | |||||
| Free Cash Flow | 760.76B | 523.73B | 787.30B | -39.08B | 813.09B |
| Operating Cash Flow | 812.03B | 550.97B | 816.45B | -11.34B | 843.26B |
| Investing Cash Flow | -1.07T | -805.99B | -539.43B | -22.24B | -395.56B |
| Financing Cash Flow | 188.63B | 111.86B | 119.86B | 53.05B | 74.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$1.17T | 8.32 | 11.95% | 4.26% | -4.57% | 1.77% | |
77 Outperform | HK$2.27T | 5.23 | 9.77% | 5.64% | -4.61% | 0.94% | |
76 Outperform | HK$2.60T | 6.66 | 9.18% | 4.81% | -2.85% | 10.49% | |
75 Outperform | HK$1.95T | 5.41 | ― | 5.67% | -3.68% | 2.67% | |
70 Outperform | HK$2.86T | 5.61 | 9.18% | 5.46% | -3.35% | 0.58% | |
69 Neutral | HK$684.59B | 5.10 | 7.92% | 6.06% | -4.42% | -2.55% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |